Severe hyperglycemia in an HIV clinic: Preexisting versus drug-associated diabetes mellitus

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 17, Issue 1, 1998, Pages 46-50

  Kilby, J Michael ^a,b   Tabereaux, Paul B ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Corticosteroids; Diabetes mellitus; Didanosine; Human immunodeficiency virus; Hyperglycemia; Megestrol acetate; Pentamidine

Indexed keywords

AMYLASE; CD4 ANTIGEN; CORTICOSTEROID; DIDANOSINE; GLUCOSE; INSULIN; MEGESTROL ACETATE; ORAL ANTIDIABETIC AGENT; PENTAMIDINE; PREDNISONE; TRIACYLGLYCEROL LIPASE;

ADULT; AEROSOL; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CENTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; INHALATIONAL DRUG ADMINISTRATION; INSULIN TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE COUNT; MALE; MEDICAL RECORD; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031963566     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199801010-00007     Document Type: Article

References (20)

1. Balow JE. Complications of therapy. In: Boumpas DT, moderator. Glucocorticoid therapy for immune mediated diseases: basic and clinical correlates. Ann Intern Med 1993;119:1205-7.
2. Liegl U, Bogner JR, Goebel FD. Insulin-dependent diabetes mellitus following pentamidine therapy in a patient with AIDS. Clin Invest 1994;72:1027-9.
3. Assan R, Perronne C, Assan D, et al. Pentamidine-induced derangements of glucose homeostasis: determinant roles of renal failure and drug accumulation - a study of 128 patients. Diabetes Care 1995;18:47-55.
4. Nasti G, Zanette G, Inchiostro S, et al. Diabetes mellitus following intravenous pentamidine administration in a patient with HIV infection [Letter]. Arch Intern Med 1995;155:645-6.
5. Hauser L, Sheehan P, Simpkins H. Pancreatic pathology in pentamidine-induced diabetes in acquired immunodeficiency syndrome patients. Hum Pathol 1991;22:926-9.
6. Millard PS, van der Horst C. Reversible diabetes mellitus after intravenous pentamidine [Letter]. Am J Med 1991;91:442.
7. Herchline TE, Plouffe JF, Para MF. Diabetes mellitus presenting with ketoacidosis following pentamidine therapy in patients with acquired immunodeficiency syndrome. J Infect 1991;22:41-4.
8. Perronne C, Bricaire F, Leport C, et al. Hypoglycemia and diabetes mellitus following parenteral pentamidine mesylate treatment in AIDS patients. Diabet Med 1990;7:585-9.
9. Chen JP, Braham RL, Squires KE. Diabetes after aerosolized pentamidine [Letter]. Ann Intern Med 1991;114:913-4.
10. Leinung MC, Liporace R, Miller CH. Induction of adrenal suppression by megestrol acetate in patients with AIDS. Ann Intern Med 1995;122:842-5.
11. Salinas I, Lucas A, Clotet B. Secondary diabetes induced by megestrol acetate therapy in a patient with AIDS-associated cachexia [letter]. AIDS 1993;7:894.
12. Panwalker AP. Hyperglycemia induced by megestrol acetate [letter]. Ann Intern Med 1992;116:878.
13. Henry K, Rathgaber S, Sullivan C, McCabe K. Diabetes mellitus induced by megestrol acetate in a patient with AIDS and cachexia. Ann Intern Med 1992;116:53-4.
14. Chidiac C, Alfandari S, Caron J, Mouton Y. Diabetes mellitus following treatment of AIDS with didanosine [letter]. AIDS 1995; 9:215-6.
15. Vittecoq D, Zucman D, Auperin I, Passeron J. Transient insulin-dependent diabetes mellitus in an HIV-infected patient receiving didanosine [letter]. AIDS 1994;8:1351.
16. Munshi MN, Martin RE, Fonseca VA. Hyperosmolar nonketotic diabetic syndrome following treatment of human immunodeficiency virus infection with didanosine. Diabetes Care 1994;17:316-7.
17. Albrecht H, Stellbrink HJ, Arasteh K. Didanosine-induced disorders of glucose tolerance [letter]. Ann Intern Med 1993;119:1050.
18. Troisvallets D, Trylesinski A, Sehouane R, et al. Diabetes mellitus: a rare and unexpected side effect of didanosine in AIDS patients [abstract LM14]. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, 1995.
19. Wetterhall SF, Olson DR, DeStefano F, et al. Trends in diabetes and diabetic complications, 1980-87. Diabetes Care 1992;15: 960-7.
20. Geiss LS, Herman WH, Goldschmid MG, et al. Surveillance for diabetes mellitus - United States, 1980-89. MMWR CDC Surveill Summ 1993;42:1-20.